<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00707200</url>
  </required_header>
  <id_info>
    <org_study_id>07-0548-AE</org_study_id>
    <secondary_id>HS 356</secondary_id>
    <secondary_id>ISBT 777531237</secondary_id>
    <nct_id>NCT00707200</nct_id>
  </id_info>
  <brief_title>The Cytoadherence in Pediatric Malaria (CPM) Study</brief_title>
  <acronym>CPM</acronym>
  <official_title>Clinical Outcomes in Pediatric Plasmodium Falciparum Malaria According to Host Cytoadherence Factors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Toronto</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Health Network, Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the importance of key blood group molecules in the&#xD;
      clinical outcome of Plasmodium falciparum malaria infection in children.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Every year, nearly 2 million children die from infection with Plasmodium falciparum malaria.&#xD;
      When red blood cells (RBC) become infected with malaria, a sticky parasite-derived knob&#xD;
      protein, termed PfEMP-1, erupts on the RBC surfaces. PfEMP-1 attaches to several blood group&#xD;
      molecules, including those found on other RBC, on blood vessels, and on the cells that&#xD;
      normally help to stop bleeding (platelets). The cellular sticking results in a dangerous&#xD;
      interruption in blood flow to vital organs, causing brain injury (cerebral malaria), systemic&#xD;
      shock (lactic acidosis), and death. Depending on an individual's inherited blood groups of&#xD;
      relevance, adhesion may be extensive or limited. In the laboratory, PfEMP-1 adheres to RBCs&#xD;
      via the A or B (but not the O) antigens of the ABO blood group system, and to platelets and&#xD;
      blood vessels via platelet glycoprotein IV (CD36) and ICAM-1. Consistent with the expected&#xD;
      evolutionary advantage of being deficient in these binding targets, blood type O and&#xD;
      low-expression of CD36 are found more frequently among Africans. The &quot;Cytoadherence in&#xD;
      Pediatric Malaria&quot; (CPM) project is determining the distribution of adhesive blood group&#xD;
      molecules in a cohort of 2000 Ugandan children according to the extent of malaria severity&#xD;
      and death, and thus their ultimate clinical and evolutionary significance in malarial&#xD;
      survival. This knowledge may serve as the grounds for developing targeted&#xD;
      cytoadhesion-interruption therapies in our fight against malaria.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2007</start_date>
  <completion_date type="Actual">November 2009</completion_date>
  <primary_completion_date type="Actual">November 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Combined severe morbidity &amp; mortality</measure>
    <time_frame>Discharge</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Laboratory indices of potential cytoadhesion (lactate, cell counts)</measure>
    <time_frame>Presentation</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Plasmodium Falciparum Malaria</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Cases: Severe inpatient malaria, survivors or decedents. Severe malaria consists of any one or combination of severe malarial anemia (SMA), cerebral malaria (CM), lactic acidosis (LA), or a respiratory distress syndrome with hypoxia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>Controls: Controls consist of mildly-affected children with P falciparum malaria who are either managed as inpatients or outpatients.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Freshly frozen citrated plasma aliquots, frozen spun red cell pellets, and whole blood blots&#xD;
      onto nucleic acid storage cards (Whatman FTA).&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Children, age 6 months to 12 years, with symptomatic malaria and (asexual) Plasmodium&#xD;
        falciparum parasitemia.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Clinical diagnosis of Plasmodium falciparum malaria infection&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  HIV or significant malnutrition&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nicolette Nabukeera-Barungi, MBChB, MMEd</last_name>
    <role>Study Director</role>
    <affiliation>Mulago Hospital/Makerere University (lead local investigator)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mulago Hospital Acute Care Unit &amp; Makerere University Department of Paediatrics &amp; Child Health</name>
      <address>
        <city>Kampala</city>
        <country>Uganda</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Uganda</country>
  </location_countries>
  <reference>
    <citation>Cserti CM, Dzik WH. The ABO blood group system and Plasmodium falciparum malaria. Blood. 2007 Oct 1;110(7):2250-8. Epub 2007 May 14. Review.</citation>
    <PMID>17502454</PMID>
  </reference>
  <results_reference>
    <citation>Cserti-Gazdewich CM, Dzik WH, Dorn ME, Quagliaroli RO, Xu S, Ssewanyana I, Nayyar R, Preffer FI. Quantitation of CD36 (platelet glycoprotein IV) expression on platelets and monocytes by flow cytometry: application to the study of Plasmodium falciparum malaria. Cytometry B Clin Cytom. 2009 Mar;76(2):127-34. doi: 10.1002/cyto.b.20443.</citation>
    <PMID>18671254</PMID>
  </results_reference>
  <verification_date>July 2009</verification_date>
  <study_first_submitted>June 26, 2008</study_first_submitted>
  <study_first_submitted_qc>June 27, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 30, 2008</study_first_posted>
  <last_update_submitted>January 22, 2010</last_update_submitted>
  <last_update_submitted_qc>January 22, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 26, 2010</last_update_posted>
  <responsible_party>
    <name_title>Christine Cserti-Gazdewich</name_title>
    <organization>University Health Network</organization>
  </responsible_party>
  <keyword>severe malarial anemia (SMA)</keyword>
  <keyword>cerebral malarial (CM)</keyword>
  <keyword>lactic acidosis</keyword>
  <keyword>hyperparasitemia</keyword>
  <keyword>respiratory distress</keyword>
  <keyword>hypoxia</keyword>
  <keyword>death</keyword>
  <keyword>transfusion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Malaria</mesh_term>
    <mesh_term>Malaria, Falciparum</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

